Manufacturer of Controlled Substances; Notice of Registration, 46234 [E9-21532]

Download as PDF 46234 Federal Register / Vol. 74, No. 172 / Tuesday, September 8, 2009 / Notices of controlled substances listed in schedules I and II: DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Manufacturer of Controlled Substances; Notice of Registration By Notice dated April 17, 2009, and published in the Federal Register on April 29, 2009, (74 FR 19599), Norac Inc., 405 S. Motor Avenue, P.O. Box 577, Azusa, California 91702–3232, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Methamphetamine (1105), a basic class of controlled substance listed in schedule II. The company plans to manufacture bulk controlled substances for use in product development and for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 USC 823(a) and determined that the registration of Norac, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Norac, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 USC 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Schedule Tetrahydrocannabinols (7370) ..... Ecgonine (9180) ........................... Morphine (9300) ........................... I II II The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/controls which are DEA exempt products. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Siemens Healthcare Diagnostics Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Siemens Healthcare Diagnostics Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: August 28, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–21531 Filed 9–4–09; 8:45 am] Drug Oxycodone (9143) ........................ Hydromorphone (9150) ................ Diphenoxylate (9170) ................... Ecgonine (9180) ........................... Hydrocodone (9193) ..................... Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... II II II II II II II II II The company plans to manufacture the listed controlled substances as bulk controlled substance intermediates for distribution to its customers for further manufacture or to manufacture pharmaceutical dosage forms. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Penick Corporation to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Penick Corporation to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: August 21, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–21529 Filed 9–4–09; 8:45 am] Dated: August 21, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–21532 Filed 9–4–09; 8:45 am] BILLING CODE 4410–09–P Drug Enforcement Administration BILLING CODE 4410–09–P BILLING CODE 4410–09–P Manufacturer of Controlled Substances; Notice of Registration DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE By Notice dated April 17, 2009, and published in the Federal Register on April 29, 2009, (74 FR 19597), Penick Corporation, 33 Industrial Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration jlentini on DSKJ8SOYB1PROD with NOTICES Schedule By Notice dated April 17, 2009, and published in the Federal Register on April 29, 2009, (74 FR 19598), Siemens Healthcare Diagnostics Inc., Attn: RA, 100 GBC Drive, Mail Stop 514, Newark, Delaware 19702, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes VerDate Nov<24>2008 17:32 Sep 04, 2009 Jkt 217001 Drug Schedule Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. PO 00000 Frm 00155 Fmt 4703 Sfmt 4703 II II II Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated April 17, 2009, and published in the Federal Register on April 29, 2009, (74 FR 19598), AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: E:\FR\FM\08SEN1.SGM 08SEN1

Agencies

[Federal Register Volume 74, Number 172 (Tuesday, September 8, 2009)]
[Notices]
[Page 46234]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-21532]



[[Page 46234]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 17, 2009, and published in the Federal 
Register on April 29, 2009, (74 FR 19599), Norac Inc., 405 S. Motor 
Avenue, P.O. Box 577, Azusa, California 91702-3232, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of Methamphetamine (1105), a basic class of 
controlled substance listed in schedule II.
    The company plans to manufacture bulk controlled substances for use 
in product development and for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 USC 823(a) and determined that the registration of 
Norac, Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Norac, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 USC 823, and in accordance with 21 CFR 1301.33, the above named 
company is granted registration as a bulk manufacturer of the basic 
class of controlled substance listed.

    Dated: August 21, 2009.
Joseph T. Rannazzisi,
 Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-21532 Filed 9-4-09; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.